Clinivation's Global Market Clearance services leverage our excellence in market clearance and many years of focused, successful experience in developing and supporting thousands of medtech market clearance applications in all of the major and emerging world markets. Our many years of successful experience spans from comprehensive initiation, support, and execution of the most complex Class III PMA programs to focused global market clearance initiatives.

Woorhi Medical Group (WMG), based in Seoul, has several subsidiary companies in Korea and many international marketing partners in the United States, France, Germany, Canada, Belgium, Singapore, Hong Kong and Japan.

WMG's international partnerships started in the United States when they signed an exclusive distribution agreement with Padgett in 1992. With this successful first step into the international market place, WMG became one of the well-known corporations in the Korean plastic surgery market. In 2001, WMG acquired exclusive distributorship of Juvederm, a filler product manufactured by Allergan. Not satisfied with these successive accomplishments WMG kept making every effort to advance its R&D power, and finally assumed a top seat in the Korean markets for the "Johns Method" of filler injection.

Currently WMG is engaged in business relationships with over 20 overseas companies and distributing 27 products in Korea.

For more information, please visit www.woorhi.co.kr.

Clinivation is the leading provider of integrated solutions that enable global market clearance. Guided by our singular vision - "Excellence in Market Clearance" - clinivation accelerates the entire market clearance cycle to advance new worldwide revenue and achieve new milestones of enterprise value.

Used in over 1,000,000 product registrations by more than 100 companies worldwide, clinivation's end-to-end technology and services deliver on our vision by eliminating revenue traps from global market clearance operations, increasing process velocity with on-demand regulatory intelligence, automating clearance-driven business controls, simplifying content unification into market clearance applications, aligning quality systems with global market clearance priorities, streamlining clinical development with clearance-focused trials, and enabling management with key performance indicators for continuous improvement and effective governance.

The world's leading medical device, diagnostics, hospital supply, and dental supply companies select clinivation because of our medtech industry focus and our unique, integrated solutions that seamlessly adapt to existing business processes and enterprise infrastructure- without the need to write custom code.

Our core brands include the clinivation Global^® xi market clearance platform, clinivation WorldView^® on-demand regulatory intelligence, and clinivation Clinical Suite^® and clinivation Registry Suite^® electronic data capture and clinical data management software.

Founded in 1999, the company is headquartered in Natick, Massachusetts, with regional offices in North America and Asia.

Visit clinivation online at www.clinivation.com

For more information on clinivation's integrated solutions that enable global market clearance, please click here or call us at 508.655.6560.